Aimed Alliance Urges CMS to Prioritize Transparency in IRA Negotiations
On June 26, 2025, Aimed Alliance submitted a comment to the Centers for Medicare & Medicaid Services (CMS) on its…
Browsing: Drug Pricing
New Analysis Warns IRA Changes Could Raise Drug Costs for Most Medicare Beneficiaries
The Inflation Reduction Act (IRA) aimed to lower prescription drug costs by capping annual out-of-pocket spending for Medicare beneficiaries at…
Aimed Alliance Opposes Nevada’s MFP Bill
Aimed Alliance sent a letter to Governor Lombardo opposing Nevada Assembly Bill 259, which would cap health plan reimbursement for…
IRA Price Controls May Be Linked to Higher Out-of-Pocket Drug Costs
A new analysis from the Pioneer Institute shows that federal price controls under the Inflation Reduction Act (IRA) may be…
Oregon Senator Delays Bill Granting PDAB UPL Authority Amid Uncertainty
Oregon Senator Deb Patterson, Chair of the Senate Health Care Committee, has decided not to introduce a bill this session…
Youngkin Vetoes PDAB Bill in Virginia for Second Year
For the second consecutive year, Governor Glenn Youngkin has vetoed legislation aimed at establishing a Prescription Drug Affordability Board (PDAB).…
Aimed Alliance Urges Illinois Lawmakers to Strengthen Patient Protections in Prescription Drug Pricing Board
On March 17, Aimed Alliance sent a letter to Illinois Legislature urging the General Assembly to amend S.B. 66, which…
Aimed Alliance Encourages Michigan to Consider PDAB Alternatives
On March 17, Aimed Alliance sent a letter to the Michigan legislature urging the Senate Committee on Finance, Insurance, and…
Aimed Alliance Calls for PBM Reform in West Virginia
On March 19, Aimed Alliance sent a letter to West Virginia legislature urging the House Committee on Health and Human…
Aimed Alliance Asks Kansas to Consider Alternative to PDAB Legislation
Aimed Alliance submitted a letter to the Kansas Legislature, urging the Committee on Financial Institutions and Insurance to evaluate the…